Komori
Astellas Pharma (4503) · InitiativeAchieved

Expansion of the healthcare solutions platform through the acquisition of Iota Biosciences

First written in FY2021-Q3. 1 of 1 entries say "Achieved", first in FY2021-Q3. Latest entry: FY2021-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Acquisition of Iota Biosciences to Establish a Biomedical Solutions PlatformA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021-Q3AchievedAnnual report

    「当社の子会社であるアステラス US ホールディング Inc.は、米国のスタートアップ企業であるIota Biosciences, Inc.との間で、同社を買収する契約を締結しました。この契約に基づき、米国西海岸時間 2020年10月29日に同社の買収が完了し、同社を当社の完全子会社としました。」

    Iota Biosciences, Inc.の買収を2020年10月29日に完了し、完全子会社化した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Astellas Pharma's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.